Skip to main content
Clinical Trials/CTRI/2024/02/062577
CTRI/2024/02/062577
Not yet recruiting
未知

Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk using ASCVD Risk Estimator Plus in Indian Patients – A Real-world, Retrospective Study from Electronic Medical Records (HEART-STRONG Study) - HEART-STRONG

Sun Pharma Laboratories Ltd.0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sun Pharma Laboratories Ltd.
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex between 20\-79 years of age
  • Patients with SBP between 90\-200 mmHg
  • Patients with DBP between 60\-130 mmHg
  • Patients with TC between 130\-320 mgdL
  • Patients with HDL cholesterol between 20\-100 mgdL
  • Patients with data on the history of diabetes (Yes No)
  • Patients with data on smoking status (current former never)
  • Patients with data on hypertension treatment (Yes no)
  • Patients with LDL between 30\-300 mgdL
  • Patients with data on statin therapy (Yes No)

Exclusion Criteria

  • Patients with current ASCVD and history of ASCVD (i.e. CHD, such as myocardial infarction, angina, and coronary artery stenosis; Cerebrovascular disease, such as a transient ischemic attack, ischemic stroke, and carotid artery stenosis; Peripheral artery disease, such as claudication; Aortic atherosclerotic disease, such as abdominal aortic aneurysm and descending thoracic aneurysm).
  • Patients with incomplete medical records with respect to the required study parameters

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
evaluation of atherosclerotic vascular lesions and terminal diseases as well as cardiovascular risk factors and experimental biomarkers in patients with primary sjögren-syndromeM35.0I70.9Sicca syndrome [Sjögren]Generalized and unspecified atherosclerosis
DRKS00026261Medizinische Hochschule Hannover in Kooperation mit der Else-Kröner-Fresenius-Stiftung317
Recruiting
Phase 1
Assessment of subclinical atherosclerosis demonstrated by coronary artery calcification in familial hypercholesterolemia patients compared with non-familial hypercholesterolemia patientsfamilial hypercholesterolemianon&#45familial hypercholesterolemiacoronary artery calcium scoreaortic valve calcium scorehypercholesterolemia
TCTR20201014001Ratchadaphiseksomphot Endowment Fund70
Not yet recruiting
Not Applicable
To find out if subclinical atherosclerosis is more common in patients of psoriasis without metabolic syndrome compared to those patients of psoriasis not having metabolic syndromeHealth Condition 1: L400- Psoriasis vulgaris
CTRI/2021/07/035003DR D Y Patil Medical College and Hospital
Completed
Not Applicable
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune SystemAtherosclerosisChronic Granulomatous Disease (CGD)
NCT01063309National Institute of Allergy and Infectious Diseases (NIAID)156
Not yet recruiting
Not Applicable
Study of risk of developing atherosclerosis in young, non-obese women with hair loss
CTRI/2023/09/057710Indian Asoociation of Dermatologists, Venereologists and Leprologists (IADVL)